Brooks Laboratories Ltd - 533543 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR), Regulations, 2015 For The Half Year Ended 31St March, 2019.
Compliance Certificate under Regulation 7(3) of SEBI (LODR), Regulations, 2015 for the half year ended 31st March, 2019. Brooks Laboratories Ltd - 533543 - Shareholding for the Period Ended March 31, 2019
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Brooks Laboratories Ltd - 533543 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jyoti SanchetiDesignation :- Company Secretary and Compliance Officer A study in contrasts: Brooks and Bryson, both gifted, yet different
Both share lead at the end of the first round at Masters BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Credit Rating
Disclosure under Regulation 30 of SEBI (LODR)-Regulations, 2015-Credit Rating BROOKS LABORATORIES LTD. - 533543 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Brooks Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. BROOKS LABORATORIES LTD. - 533543 - Clarification Sought on Price Movement
The Exchange has sought clarification from Brooks Laboratories Ltd on February 26, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Brooks Laboratories Ltd - 533543 - Unaudited Financial Results For The 3Rd Quarter Ended 31St December, 2018
Unaudited Financial Results for the 3rd quarter ended 31st December, 2018 Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for To Approve The Unaudited Financial Results For The 3Rd Quarter Ended 31.12.2018
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve Unaudited Financial Results for the 3rd quarter ended 31.12.2018 BROOKS LABORATORIES LTD. - 533543 - Shareholding for the Period Ended December 31, 2018
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here